Literature DB >> 19740128

Early loss of pregnancy after intravitreal bevacizumab injection.

Petros Petrou, Ilias Georgalas, Georgios Giavaras, Eleni Anastasiou, Zoi Ntana, Constantinos Petrou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19740128     DOI： 10.1111/j.1755-3768.2009.01572.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  21 in total

Review 1.  [Ophthalmic agents during pregnancy and breastfeeding].

Authors:  T Ness; W Paulus
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

2.  [Eye and pregnancy.].

Authors:  T Ness; W Paulus
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

3.  Idiopathic choroidal neovascularisation in pregnancy: treatment options and a successful outcome.

Authors:  Samantha Roshani De Silva; Farhat Bibi; Kuan Sim; Mandeep Singh Bindra
Journal:  BMJ Case Rep       Date:  2016-07-19

4.  Transfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheep.

Authors:  Tugba Cakmak Argun; Ozlem Yalcin Tok; Levent Tok; Gulsen Yilmaz; Fatma Meric Yilmaz; Alime Gunes; Mehmet Argun; Osman Butuner
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

5.  Dexamethasone intravitreal implant for diabetic macular edema in a pregnant patient.

Authors:  Romi Yoo; Hyung Chan Kim; Hyewon Chung
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

Review 6.  Ocular changes during pregnancy.

Authors:  Friederike Mackensen; Wolfgang E Paulus; Regina Max; Thomas Ness
Journal:  Dtsch Arztebl Int       Date:  2014-08-18       Impact factor: 5.594

Review 7.  Management of gynecological cancers during pregnancy.

Authors:  Sileny N Han; Magali Verheecke; Tineke Vandenbroucke; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Curr Oncol Rep       Date:  2014-12       Impact factor: 5.075

Review 8.  Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab.

Authors:  C H Meyer; F G Holz
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

9.  Intravitreal bevacizumab injection in unrecognised early pregnancy.

Authors:  L Sullivan; S P Kelly; A Glenn; C P R Williams; M McKibbin
Journal:  Eye (Lond)       Date:  2014-01-17       Impact factor: 3.775

Review 10.  Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Authors:  Kelvin Yi Chong Teo; Wei Yan Ng; Shu Yen Lee; Chui Ming Gemmy Cheung
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.